Log In
Print
BCIQ
Print
Print this Print this
 

THA902

  Manage Alerts
Collapse Summary General Information
Company Theralpha S.A.S.
DescriptionLong-acting formulation ASIC3 inhibitor using Medusa technology
Molecular Target Acid-sensing ion channel-3 (ASIC3) (ACCN3)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation

Partner

Flamel Technologies S.A.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today